Bio-Matrix Scientific Group Announces New Hires to Management Team
Posted on: Wednesday, 25 February 2009, 09:30 CST
SAN DIEGO, Feb. 25 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group,
Inc. (OTC Bulletin Board: BMSN) announced today that it has added two members
to newly created positions on its management team. Feng Lin, M.D., Ph.D. has
joined the biotech research and development company as Laboratory/Scientific
Director and Marilyn Panahi is serving as Quality Assurance Director.
"Dr. Feng Lin and Marilyn Panahi bring tremendous expertise to the
administrative operations of BMSN's laboratories to ensure all of the varied
facets meet government regulations and compliance," said David Koos, Chairman
and CEO, BMSN.
As Laboratory/Scientific Director, Dr. Lin is responsible for the overall
operation, leadership, direction, and administration of BMSN's Laboratory in
accordance with Federal and State Regulations governing laboratories.
As Quality Assurance Director, Ms. Panahi is responsible for managing and
assuring regulatory compliance requirements including validation, customer
complaints, and review of product manufacture records, audits, and quality
assurance documentation. .
Dr. Feng Lin has a strong background in drug/DNA in vivo delivery,
oncology and tumor immunotherapy, DNA vaccination, cell and molecular biology,
and animal model work. He also has extensive experience with tissue imaging,
DNA vaccine design, antibody- and cell-based assay. Previously, Dr. Lin was a
Senior Research Scientist, Research & Development with Inovio Biomedical
Corp., San Diego. He received his M.D. from Central South University Xiag-Ya
School of Medicine, Changsha, China, along with a M.S. Biochemistry &
Molecular Biology and a Ph.D. Hematology & Physiology from the same
institution. Dr. Lin's research work has been widely published in
international scientific journals.
Marilyn Panahi brings more than 15 years experience in the implementation
and management of the EPA's Good Laboratory Practice Standards (GLPS)
Compliance Monitoring Program and the FDA's Good Manufacturing Practices
(GMP)/Quality Systems Regulation.
Previously, Ms. Panahi was Quality Manager, Therapheresis, Inc., San
Diego. Ms. Panahi is a graduate of San Diego State University with a B.S. in
Microbiology. Ms. Panahi also holds a Certificate in Science of Regulatory
Affairs for the Drug and Biologic Industry and a Certificate in Quality
Assurance/Control for the Drug and Biologic Industry, both from the University
of California at San Diego.
About Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN)
Bio-Matrix Scientific Group, Inc., based in San Diego, is a biotech
research and development company that commercializes medical devices and
monitoring systems for the growing, worldwide stem cell research market. The
company aligns itself with strategic partners that offer key technologies in
biomedical device development, tissue partners that offer key technologies in
biomedical device development, tissue engineering, cell culturing, genome
therapy and drug delivery systems to become a leading source for stem cell
research technology and innovation. Bio-Matrix's new 15,000 sq. ft. facility,
located in the heart of San Diego's biotechnology corridor, houses the
company's two secure Cryogenic Stem Cell Banks, three research laboratories,
aseptic cellular/tissue class 10,000/100 processing laboratory, hematology,
microbiology and flow cytometry laboratories.
SOURCE Bio-Matrix Scientific Group, Inc.
Source: PR Newswire
More News in this Category
RSS Feeds